IP Library Granted Patent US 7,598,397
Granted Patent B2
US 7,598,397 · App. 11/169,161 · Granted Oct 6, 2009

Sulfonamide peri-substituted bicyclics for occlusive artery disease

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,598,397
App. No.
11/169,161
Granted
Oct 6, 2009
Kind
B2
Abstract

Acyl sulfonamide, peri-substituted, fused bicyclic ring compounds useful for the treatment or prophylaxis of a prostaglandin-mediated disease or condition are disclosed. The compounds are of the general formula A representative example is:

Claims (27)

1. A compound of formula

wherein

A and B represent a six-membered carbocycle fused to a five-membered nitrogen heterocycle, said A/B ring system chosen from indole, reduced indole, 2-oxoindole, and reduced 2-oxoindole, and said fused A/B ring system substituted with from zero to four substituents chosen independently from halogen, —OH, loweralkyl, —O-loweralkyl, fluoroloweralkyl, —O-lowerfluoroalkyl, methylenedioxy, ethylenedioxy, alkoxy-loweralkyl, hydroxylloweralkyl, oxo, oxide, —CN, nitro, —S-loweralkyl, amino, loweralkylamino, diloweralkylamino, diloweralkylaminoalkyl, carboxy, carboalkoxy, orthoester, acyl, acylalkyl, carboxamido, loweralkylsulfoxide, loweralkylsulfone, acylamino, phenyl, benzyl, spirothiazolidinyl, phenoxy and benzyloxy;

a and b represent points of attachment of residues Y and W respectively and a and b are in a peri relationship to one another on said fused A/B ring system;

d and e represent points of fusion between ring A and ring B in said fused A/B ring system;

Each of the nodes a, b, d and e may be either carbon or nitrogen;

W is chosen from —CH 2 O—, —OCF 2 —, —OC(CH 3 )—, —CH=CH—, and —NHCH 2 ;

Y is chosen from —CH 2 —, —O—, —OCH 2 —, —S—, —SO—, and —SO 2 —;

M is chosen from aryl, substituted aryl, heterocyclyl, and substituted heterocyclyl wherein substituents on substituted aryl and heterocyclyl are chosen from halogen, loweralkyl, haloalkyl, hydroxy, loweralkoxy. carboxy, carboalkoxy, carboxamido, cyano, carbonyl, nitro, amino, alkylamino, dialkylamino, mercapto, alkylthio, sulfoxide, sulfone, acylamino, amidino, phenyl, benzyl, heteroaryl, phenoxy, benzyloxy, and heteroaryloxy;

Q is chosen from —N(SO 2 R 1 )—, —N(COR 1 )—, —N(CO 2 R 1 )—, —N[PO(O-alkyl) 2 ]—, and —NHNR 10 (SO 2 R 1 )—;

R 1 is chosen from phenyl, isoxazole, thienyl, substituted isoxazole, substituted thienyl, C 3 -C 20 alkyl and fluoroalkyl; and

R 10 is chosen from alkyl, aryl and heteroaryl.

2. A compound according to claim 1 wherein said A/B ring system is indole of formula:

wherein

R 3 and R 4 are optional substituents in either or both rings, chosen independently from halogen, —OH, loweralkyl, —O-loweralkyl, fluoroloweralkyl, —O-lowerfluoroalkyl, methylenedioxy, ethylenedioxy, alkoxy-loweralkyl, hydroxyloweralkyl, oxo, oxide, —CN, nitro, —S-loweralkyl, amino, loweralkylamino, diloweralkylamino, diloweralkylaminoalkyl, carboxy, carboalkoxy, orthoester, acyl, acylalkyl, carboxamido, loweralkylsulfoxide, loweralkylsulfone, acylamino, phenyl, benzyl, spirothiazolidinyl, phenoxy and benzyloxy.

3. A compound according to claim 1 wherein said A/B ring system is 2-oxoindole of formula:

wherein

R 3 and R 4 are optional substituents in either or both rings, chosen independently from halogen, —OH, loweralkyl, —O-loweralkyl, fluoroloweralkyl, —O-lowerfluoroalkyl, methylenedioxy, ethylenedioxy, alkoxy-loweralkyl, hydroxyloweralkyl, oxo, oxide, —CN, nitro, —S-loweralkyl, amino, loweralkylamino, diloweralkylamino, diloweralkylaminoalkyl, carboxy, carboalkoxy, orthoester, acyl, acylalkyl, carboxamido, loweralkylsulfoxide, loweralkylsulfone, acylamino, phenyl, benzyl, spirothiazolidinyl, phenoxy and benzyloxy.

4. A compound according to claim 1 wherein said A/B ring system is a reduced 2-oxoindole of formula:

wherein

R 3 and R 4 are substituents in either or both rings, chosen independently from halogen, —OH, loweralkyl, —O-loweralkyl, fluoroloweralkyl, —O-lowerfluoroalkyl, methylenedioxy, ethylenedioxy, alkoxy-loweralkyl, hydroxyloweralkyl, oxo, oxide, —CN, nitro, —S-loweralkyl, amino, loweralkylamino, diloweralkylamino, diloweralkylaminoalkyl, carboxy, carboalkoxy, orthoester, acyl, acylalkyl, carboxamido, loweralkylsulfoxide, loweralkylsulfone, acylamino, phenyl, benzyl, spirothiazolidinyl, phenoxy and benzyloxy.

5. A compound according to any one of claims 1 - 4 wherein Q is —N(SO 2 R 1 )— and R 1 is chosen from phenyl, substituted phenyl, isoxazole, substituted isoxazole, thienyl, substituted thienyl, fluorophenyl and CF 3.

6. A compound according to claim 5 wherein M is chosen from substituted phenyl, naphthyl and bicyclic nitrogen heteroaryl.

7. A compound according to claim 6 wherein at least one of R 1 and M is fluorophenyl.

8. A compound according to claim 6 wherein Y is —CH 2 — and W is —CH=CH—.

9. A compound according to claim 2 which is

10. A compound according to claim 9 wherein M is 2,4—dichiorophenyl and R 1 is 4,5—dichlorothien—2—yl.

Assignments (3)
GRANT OF PATENT SECURITY INTEREST Recorded Nov 12, 2009
From: DECODE GENETICS EHF (IN ICELANDIC: ISLENSK ERFDAGREINING EHF)
To: SAGA INVESTMENTS LLC
Reel/Frame 023510/0243 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 4, 2008
From: DECODE GENETICS, INC.
To: DECODE GENETICS EHF
Reel/Frame 021037/0917 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2005
From: SINGH, JASBIR; GURNEY, MARK E.; HATEGAN, GEORGETA; YU, PENG; ZEMBOWER, DAVID; ZHOU, NIAN
To: DECODE GENETICS, INC.
Reel/Frame 016521/0894 →